Supply Chain Models for Global Trials - Singapore as the APAC Gateway to the World
Summary: In 2018, over 40% of new clinical studies had sites in the APAC region (according to clinicaltrials.gov), and this trend is expected to continue to grow in the coming years. Because of this, the need for streamlined support strategies for the distribution of clinical supplies will also increase. From well-established regulations to an excellent infrastructure, Singapore is an ideal gateway into the region for sponsors.